TLR2 and rheumatoid arthritis: found that increased expression of TXNDC5, toll like receptor 2 (TLR2) and epidermal growth factor receptor (EGFR) could be suppressed by enhancing miR-573 expression during TXNDC5-induced RA, thereby alleviating inflammation (53).